Treatment of Bacterial Conjunctivitis with Copious Purulent Discharge, Pain, and Marked Inflammation
This protocol addresses the moderate-to-severe presentation of bacterial conjunctivitis — a clinically distinct scenario defined by copious purulent discharge, significant ocular pain, and marked inflammation of the eye.
Clinical scenario
Moderate to severe bacterial conjunctivitis is characterised by copious purulent discharge, pain, and marked inflammation of the eye. This presentation calls for a more targeted diagnostic and therapeutic approach than mild disease.
Treatment approach — partial overview
Antibiotic selection in this setting is guided by the results of conjunctival cultures and Gram-stain laboratory testing, rather than relying solely on empiric therapy. The specific choice of topical antibiotic agent follows from the microbiology findings. The complete regimen and full clinical decision pathway are available in the structured protocol below.
Treatment goal: Reassessment within 3 to 4 days to evaluate for clinical improvement.
References
- Moderate to severe bacterial conjunctivitis is characterized by copious purulent discharge, pain, and marked inflammation of the eye.
- In these cases, the choice of antibiotic is guided by the results of laboratory tests.
- Microbiology laboratory testing may guide therapy, which may include compounded topical antibiotics such as vancomycin (see Bacterial Keratitis PPP).
- For other types of bacterial conjunctivitis, patients should be advised to return for a visit in 3 to 4 days if they note no improvement.